Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating safety, tolerability, and dose range of ICM-203 in mild to moderate knee osteoarthritis. The study is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• ICM-203 (ICM-203)

Snippet

Sponsor: ICM Biotech Australia Pty Ltd. | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING